Kelly De Groot

NPI: 1538753983
Total Payments
$3,708
2024 Payments
$889.97
Companies
27
Transactions
149
Medicare Patients
127
Medicare Billing
$9,304

Payment Breakdown by Category

Food & Beverage$3,696 (99.7%)
Education$11.71 (0.3%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,696 148 99.7%
Education $11.71 1 0.3%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $866.96 30 $0 (2024)
AstraZeneca Pharmaceuticals LP $749.82 13 $0 (2024)
ABBVIE INC. $581.84 28 $0 (2024)
Biohaven Pharmaceutical Holding Company Ltd. $200.33 13 $0 (2022)
Paratek Pharmaceuticals, Inc. $167.81 5 $0 (2023)
Lilly USA, LLC $158.76 10 $0 (2023)
Esperion Therapeutics, Inc. $141.50 3 $0 (2022)
Novartis Pharmaceuticals Corporation $132.99 7 $0 (2023)
Bayer Healthcare Pharmaceuticals Inc. $109.74 6 $0 (2023)
Amgen Inc. $90.47 6 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $889.97 21 Novo Nordisk Inc ($343.40)
2023 $844.90 34 Novo Nordisk Inc ($319.92)
2022 $1,973 94 ABBVIE INC. ($313.59)

All Payment Transactions

149 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
11/14/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $12.10 General
Category: Diabetes
11/12/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $85.10 General
Category: Respiratory
11/07/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $124.99 General
Category: NEUROSCIENCE
10/30/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $25.93 General
Category: NEUROSCIENCE
10/14/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $22.26 General
Category: NEUROSCIENCE
10/02/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $6.97 General
Category: Diabetes
09/18/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $15.76 General
Category: Diabetes
09/13/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $20.09 General
Category: Respiratory
08/09/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $11.11 General
Category: Diabetes
07/31/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $111.40 General
Category: Respiratory
07/24/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $11.68 General
Category: NEUROSCIENCE
07/17/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $9.90 General
Category: Diabetes
06/06/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $6.71 General
Category: Diabetes
05/21/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $11.60 General
Category: Diabetes
05/08/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $8.33 General
Category: Diabetes
05/01/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $18.73 General
Category: NEUROSCIENCE
04/24/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $125.00 General
04/23/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $10.92 General
Category: Diabetes
02/28/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $125.00 General
02/13/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $90.66 General
Category: Respiratory
01/24/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug), BREZTRI Food and Beverage In-kind items and services $35.73 General
Category: Respiratory
12/06/2023 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $5.36 General
Category: Diabetes
10/23/2023 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $3.94 General
Category: Diabetes
08/29/2023 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $20.26 General
Category: Diabetes
06/27/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $124.99 General
Category: Cardiovascular and Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 26 29 $5,075 $1,519
2022 4 101 119 $16,080 $7,785
Total Patients
127
Total Services
148
Medicare Billing
$9,304
Procedure Codes
5

All Medicare Procedures & Services

5 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 26 29 $5,075 $1,519 29.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 42 52 $6,500 $3,061 47.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 28 34 $5,950 $2,664 44.8%
99496 Transitional care management services for problem of high complexity Office 2022 11 11 $3,300 $1,984 60.1%
81002 Urinalysis, manual test Office 2022 20 22 $330.00 $75.61 22.9%

About Kelly De Groot

Kelly De Groot is a Family healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/25/2021. The National Provider Identifier (NPI) number assigned to this provider is 1538753983.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kelly De Groot has received a total of $3,708 in payments from pharmaceutical and medical device companies, with $889.97 received in 2024. These payments were reported across 149 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,696).

As a Medicare-enrolled provider, De Groot has provided services to 127 Medicare beneficiaries, totaling 148 services with total Medicare billing of $9,304. Data is available for 2 years (2022–2023), covering 5 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Location Charlotte, NC
  • Active Since 02/25/2021
  • Last Updated 05/22/2023
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • NPI Number 1538753983

Products in Payments

  • AIRSUPRA (Drug) $342.98
  • FARXIGA (Drug) $290.24
  • Ozempic (Drug) $224.02
  • NURTEC ODT (Drug) $200.33
  • VRAYLAR (Drug) $195.10
  • NUZYRA (Drug) $167.81
  • QULIPTA (Drug) $153.90
  • UBRELVY (Drug) $150.14
  • NEXLIZET (Drug) $122.17
  • BREZTRI (Drug) $116.60
  • Kerendia (Drug) $109.74
  • LEQVIO (Drug) $85.59
  • JARDIANCE (Drug) $78.15
  • Otezla (Drug) $75.80
  • MOUNJARO (Drug) $74.65
  • Rybelsus (Drug) $69.55
  • Wegovy (Drug) $63.55
  • BELSOMRA (Drug) $54.36
  • ENTRESTO (Drug) $47.40
  • EGRIFTA (Drug) $39.79

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Charlotte